基本信息
views: 1
Career Trajectory
Bio
Our laboratory is engaged in collaborative, multidisciplinary probe- and drug-discovery programs. We specialize in the design and synthesis of small molecules as research tools or candidate therapeutics for a variety of human diseases. Our work typically involves Structure Activity and Structure Property Relationship (SAR/SPR) studies. These efforts are often directed towards the identification and development of probes suitable for mode of action studies, as well as candidate compounds optimized for pharmacokinetic and pharmacodynamic properties that could enable in vivo proof-of-concept studies or other preclinical evaluations of efficacy and safety. Over the past several years the primary focus of our research has been in the area of CNS drug discovery with specific programs directed towards the discovery and development of candidate treatments for: (a) neurodegenerative tauopathies (e.g., Alzheimer’s disease), in collaboration with the Center for Neurodegenerative Diseases Research (CNDR) at University of Pennsylvania; and (b) neuroparasitic infections (e.g., African Sleeping Sickness), in collaboration with the Center for Discovery and Innovation in Parasitic Diseases at UC San Diego. In addition, our laboratory has been actively involved in the investigation of basic, fundamental principles in medicinal chemistry, such as in the area of isosteric replacements.Over the past several years the primary focus of our research has been in the area of Alzheimer’s disease and related neurodegenerative tauopathies with specific programs directed towards the discovery and development of (a) tau aggregation inhibitors, (b) microtubule-stabilizing agents, and (c) thromboxane A2 receptor antagonists. The laboratory has also been actively involved in the investigation of basic, fundamental principles in medicinal chemistry, such as in the area of isosteric replacements.
Research Interests
Papers共 116 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ChemMedChemno. 8 (2024): e202300656-e202300656
Lawrence J Liu,Bobby Lucero, Cindy Manriquez-Rodriguez,Karol R Francisco, Thaiz R Teixeira, Darius J Yohannan,Carlo Ballatore,Samuel A Myers, Anthony J O'Donoghue,Conor R Caffrey
ACS omegano. 32 (2024): 34829-34840
CHEMMEDCHEMno. 8 (2024)
Yuemang Yao, Megan Muench,Thibault Alle, Bin Zhang,Bobby Lucero, Roxanne Perez-Tremble,Dominic Mcgrosso, Mira Newman, David J. Gonzalez,Virginia M. -Y. Lee,Carlo Ballatore,Kurt R. Brunden
Alzheimer's & dementia (2024)
ChemMedChemno. 20 (2023)
Hanna F. F. Roenfanz,Thomas J. J. Paniak, Cameron B. B. Berlin,Van Tran,Karol R. R. Francisco,Pierrik Lassalas, Anisha Devas, Olivia Landes, Avalon Rosenberger,Madeline E. E. Rotella,Carlo Ballatore,Marisa C. C. Kozlowski
HEPATOLOGY (2023): S1195-S1196
Cited0Views0Bibtex
0
0
ACS pharmacology & translational scienceno. 11 (2023): 1651-1658
Trends in pharmacological sciencesno. 7 (2023): 474-488
Load More
Author Statistics
#Papers: 116
#Citation: 5963
H-Index: 35
G-Index: 77
Sociability: 6
Diversity: 3
Activity: 36
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn